These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16865561)

  • 1. Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred.
    Kinney AY; Simonsen SE; Baty BJ; Mandal D; Neuhausen SL; Seggar K; Holubkov R; Bloor L; Smith K
    J Genet Couns; 2006 Aug; 15(4):293-305. PubMed ID: 16865561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
    Armstrong K; Micco E; Carney A; Stopfer J; Putt M
    JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation.
    Kinney AY; Croyle RT; Dudley WN; Bailey CA; Pelias MK; Neuhausen SL
    Prev Med; 2001 Dec; 33(6):543-51. PubMed ID: 11716649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.
    Botkin JR; Smith KR; Croyle RT; Baty BJ; Wylie JE; Dutson D; Chan A; Hamann HA; Lerman C; McDonald J; Venne V; Ward JH; Lyon E
    Am J Med Genet A; 2003 Apr; 118A(3):201-9. PubMed ID: 12673648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
    Lerman C; Hughes C; Croyle RT; Main D; Durham C; Snyder C; Bonney A; Lynch JF; Narod SA; Lynch HT
    Prev Med; 2000 Jul; 31(1):75-80. PubMed ID: 10896846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2 test results impact risk management attitudes, intentions, and uptake.
    O'Neill SC; Valdimarsdottir HB; Demarco TA; Peshkin BN; Graves KD; Brown K; Hurley KE; Isaacs C; Hecker S; Schwartz MD
    Breast Cancer Res Treat; 2010 Dec; 124(3):755-64. PubMed ID: 20383578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
    Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Klijn JG; Seynaeve C; Tilanus MM; Bartels CC; Meijers-Heijboer EJ; Verhoog LC; Niermeijer MF
    Am J Med Genet A; 2003 Jun; 119A(3):266-72. PubMed ID: 12784290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer.
    Claes E; Evers-Kiebooms G; Decruyenaere M; Denayer L; Boogaerts A; Philippe K; Legius E
    Behav Med; 2005; 31(3):93-105. PubMed ID: 16252621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.
    Kessler L; Domchek S; Stopfer J; Halbert CH
    Community Genet; 2008; 11(4):193-200. PubMed ID: 18417966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation.
    Kinney AY; Bloor LE; Mandal D; Simonsen SE; Baty BJ; Holubkov R; Seggar K; Neuhausen S; Smith K
    Cancer; 2005 Dec; 104(11):2508-16. PubMed ID: 16222692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic counseling and testing for breast cancer risk in African Americans.
    Halbert CH
    LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.
    Liede A; Metcalfe K; Hanna D; Hoodfar E; Snyder C; Durham C; Lynch HT; Narod SA
    Am J Hum Genet; 2000 Dec; 67(6):1494-504. PubMed ID: 11063672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
    Schwartz MD; Isaacs C; Graves KD; Poggi E; Peshkin BN; Gell C; Finch C; Kelly S; Taylor KL; Perley L
    Cancer; 2012 Jan; 118(2):510-7. PubMed ID: 21717445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer.
    Halbert CH; Kessler L; Stopfer JE; Domchek S; Wileyto EP
    Genet Med; 2006 Sep; 8(9):576-82. PubMed ID: 16980814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
    Lerman C; Hughes C; Benkendorf JL; Biesecker B; Kerner J; Willison J; Eads N; Hadley D; Lynch J
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):361-7. PubMed ID: 10207641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
    Watson M; Foster C; Eeles R; Eccles D; Ashley S; Davidson R; Mackay J; Morrison PJ; Hopwood P; Evans DG;
    Br J Cancer; 2004 Nov; 91(10):1787-94. PubMed ID: 15505627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.